New drug combo shows promise in shrinking uterine cancer cells before surgery
NCT ID NCT04049227
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study tested two drugs, abemaciclib and letrozole, in 27 women with a type of uterine cancer called endometrioid adenocarcinoma. The goal was to see if the drugs could slow down cancer cell growth before the women had surgery to remove their uterus. Researchers measured changes in a cell growth marker called Ki-67 in tumor samples taken before and after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.